TJD-AD 2019-030 Disciplinary Decision - Powerlifting

In April 2019 the Brazilian Doping Control Authority (ABCD) has reported an anti-doping rule violation against the powerlifter after his sample tested positive for the prohibited substances Metandienone, Methasterone and Trenbolone.

After notification a provisional suspension was ordered. Initially the Athlete failed to respond to the ABCD communications and only later he produced a statement in his defence. He claimed his ignorance of the anti-doping rules, he had not received anti-doping education from ABCD, nor had he participated in any competition of his Confederation.

The TJD-AD Panel finds that the presence of the prohibited substances has been established in the Athlete's sample and accordingly that he had committed an anti-doping rule violation intentionally.

Based on the evidence in this case the Panel dismisses the Athlete's assertions and finds that the Athlete failed to demonstrate that the violation was not intentional. The Panel deems that there are no grounds for a reduced sanction nor grounds to start the sanction on the date of the provisional suspension.

Therefore the TJD-AD decides on 9 August 2019 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the decision.

Original document

Parameters

Legal Source
National Decisions
Date
9 August 2019
Arbitrator
Baptista, Marta Wada
Moura, Humberto Fernandes
Silva, Guilherme Faria
Original Source
Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD)
Country
Brazil
Language
Portuguese
ADRV
Adverse Analytical Finding / presence
Legal Terms
Burdens and standards of proof
Commencement of ineligibility period
Intent
Sport/IFs
Powerlifting (IPF) - International Powerlifting Federation
Other organisations
Autoridade Brasileira de Controle de Dopagem (ABCD) - Brazilian Doping Control Authority
Tribunal de Justiça Desportiva Antidopagem (TJD-AD) - Brazilian Sports Justice Anti-Doping Tribunal
Doping classes
S1. Anabolic Agents
Substances
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Methasterone (17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one)
Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
Various
Education
Document type
Pdf file
Date generated
19 July 2022
Date of last modification
23 August 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin